Kumar A - Search Results

1

Recombinant soluble p-selectin glycoprotein ligand-1-Ig reduces restenosis through inhibition of platelet-neutrophil adhesion after double angioplasty in swine.

Bienvenu JG, Tanguay JF, Théorêt JF, Kumar A, Schaub RG, Merhi Y. Bienvenu JG, et al. Among authors: kumar a. Circulation. 2001 Feb 27;103(8):1128-34. doi: 10.1161/01.cir.103.8.1128. Circulation. 2001. PMID: 11222477

2

Prevention of in-stent restenosis via reduction of thrombo-inflammatory reactions with recombinant P-selectin glycoprotein ligand-1.

Tanguay JF, Geoffroy P, Sirois MG, Libersan D, Kumar A, Schaub RG, Merhi Y. Tanguay JF, et al. Among authors: kumar a. Thromb Haemost. 2004 Jun;91(6):1186-93. doi: 10.1160/TH03-11-0701. Thromb Haemost. 2004. PMID: 15175806

3

Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model.

Kumar A, Villani MP, Patel UK, Keith JC Jr, Schaub RG. Kumar A, et al. Circulation. 1999 Mar 16;99(10):1363-9. doi: 10.1161/01.cir.99.10.1363. Circulation. 1999. PMID: 10077522

4

P-selectin antagonism with recombinant p-selectin glycoprotein ligand-1 (rPSGL-Ig) inhibits circulating activated platelet binding to neutrophils induced by damaged arterial surfaces.

Théorêt JF, Bienvenu JG, Kumar A, Merhi Y. Théorêt JF, et al. Among authors: kumar a. J Pharmacol Exp Ther. 2001 Aug;298(2):658-64. J Pharmacol Exp Ther. 2001. PMID: 11454928

5

Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion.

Wang K, Zhou X, Zhou Z, Tarakji K, Qin JX, Sitges M, Shiota T, Forudi F, Schaub RG, Kumar A, Penn MS, Topol EJ, Lincoff AM. Wang K, et al. Among authors: kumar a. Thromb Haemost. 2002 Jul;88(1):149-54. Thromb Haemost. 2002. PMID: 12152656

6

P-selectin and leukocyte microparticles are associated with venous thrombogenesis.

Myers DD, Hawley AE, Farris DM, Wrobleski SK, Thanaporn P, Schaub RG, Wagner DD, Kumar A, Wakefield TW. Myers DD, et al. Among authors: kumar a. J Vasc Surg. 2003 Nov;38(5):1075-89. doi: 10.1016/s0741-5214(03)01033-4. J Vasc Surg. 2003. PMID: 14603220 Free article.

7

Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice.

Kumar A, Hoover JL, Simmons CA, Lindner V, Shebuski RJ. Kumar A, et al. Circulation. 1997 Dec 16;96(12):4333-42. doi: 10.1161/01.cir.96.12.4333. Circulation. 1997. PMID: 9416901

8

Evaluation of cardioprotective effects of recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in myocardial ischemia-reperfusion injury by real-time myocardial contrast echocardiography.

Hansen A, Kumar A, Wolf D, Frankenbergerova K, Filusch A, Gross ML, Mueller S, Katus H, Kuecherer H. Hansen A, et al. Among authors: kumar a. J Am Coll Cardiol. 2004 Aug 18;44(4):887-91. doi: 10.1016/j.jacc.2004.05.052. J Am Coll Cardiol. 2004. PMID: 15312876 Free article.

9

Smart Mesoporous Silica Nanoparticles in Cancer: Diagnosis, Treatment, Immunogenicity, and Clinical Translation.

Yousefiasl S, Ghovvati M, Alibakhshi A, Azizi M, Samadi P, Kumar A, Shojaeian A, Sharifi E, Zare EN, Dey AD, Chehelgerdi M, Makvandi P. Yousefiasl S, et al. Among authors: kumar a. Small. 2025 Jan 22:e2408898. doi: 10.1002/smll.202408898. Online ahead of print. Small. 2025. PMID: 39840493 Review.

10

Novel application of 5% lignocaine patch for the treatment of vesicant extravasations.

Kumar A, Singh K, Kumar A, Sinha C, Mandal P. Kumar A, et al. J Perioper Pract. 2025 Jan 22:17504589241311883. doi: 10.1177/17504589241311883. Online ahead of print. J Perioper Pract. 2025. PMID: 39840480 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32,192 results

Search Page

Filters